| ISIN | CH0461413921 |
|---|---|
| Valor Number | 46141392 |
| Bloomberg Global ID | |
| Fund Name | Swisscanto (CH) Index Equity Fund United Kingdom GT GBP |
| Fund Provider |
Swisscanto Fondsleitung AG
Zurich E-Mail: fonds@swisscanto.ch |
| Fund Provider | Swisscanto Fondsleitung AG |
| Representative in Switzerland | |
| Distributor(s) | Schweizerische Kantonalbanken |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
| Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
| Investment Strategy *** | Die Anlagen dieses Teilvermögens erfolgen in Anlehnung an den MSCI® United Kingdom Index, welcher von der MORGAN STANLEY CAPITAL INTERNATIONAL INC. (MSCI) fest-gelegt und berechnet wird und darauf ausgelegt ist, die Performance der Mid- und Large Cap Segmente des Marktes des Vereinigten Königreiches (Grossbritannien und Nordirland) zu messen. |
| Peculiarities |
| Current Price * | 157.45 GBP | 20.11.2025 |
|---|---|---|
| Previous Price * | 157.07 GBP | 19.11.2025 |
| 52 Week High * | 163.52 GBP | 12.11.2025 |
| 52 Week Low * | 124.38 GBP | 09.04.2025 |
| NAV * | 157.45 GBP | 20.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 97,479,325 | |
| Unit/Share Assets *** | 1,090,032 | |
| Trading Information SIX | ||
| YTD Performance | +20.41% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +11.71% |
31.12.2024 - 20.11.2025
31.12.2024 20.11.2025 |
| 1 month | +1.82% |
20.10.2025 - 20.11.2025
20.10.2025 20.11.2025 |
| 3 months | +3.26% |
20.08.2025 - 20.11.2025
20.08.2025 20.11.2025 |
| 6 months | +10.32% |
20.05.2025 - 20.11.2025
20.05.2025 20.11.2025 |
| 1 year | +21.81% |
20.11.2024 - 20.11.2025
20.11.2024 20.11.2025 |
| 2 years | +36.03% |
20.11.2023 - 20.11.2025
20.11.2023 20.11.2025 |
| 3 years | +43.13% |
21.11.2022 - 20.11.2025
21.11.2022 20.11.2025 |
| 5 years | +83.44% |
20.11.2020 - 20.11.2025
20.11.2020 20.11.2025 |
| Equity Participation Rate in % | 98.13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AstraZeneca PLC | 8.64% | |
|---|---|---|
| HSBC Holdings PLC | 8.29% | |
| Shell PLC | 7.50% | |
| Unilever PLC | 5.03% | |
| Rolls-Royce Holdings PLC | 4.41% | |
| British American Tobacco PLC | 3.64% | |
| GSK PLC | 3.25% | |
| BP PLC | 3.13% | |
| Rio Tinto PLC Ordinary Shares | 2.77% | |
| RELX PLC | 2.76% | |
| Last data update | 31.10.2025 | |
| TER | 0.16% |
|---|---|
| TER date | 30.09.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.30% |
| Ongoing Charges *** | 0.16% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |